Bio-Path Holdings Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Garrison Michael J., was filed 15 Jul 2015.
Bio-Path Holdings Inc: what insiders have been doing
Every trade that managers of Bio-Path Holdings Inc disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for Bio-Path Holdings Inc. The previous disclosure was published on 23 January 2019.
Since 2009, the database holds 7 purchases and 3 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +31.7%Entry US$5,040.00 · Close at T+365 US$6,640.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
- 00Common StockSEC:0000919574-19-000549:1
- 00Common StockSEC:0000919574-19-000549:2
- 64,457 shares@ US$2.6629100.0% of flowCommon StockSEC:0000919574-19-000549:0
- 7,343 shares@ US$1.22Common StockSEC:0001446472-15-000010:0Canonical exit: 11 Oct 2015 (T+90)
- 8,724 shares@ US$1.17Common StockSEC:0001446472-15-000008:0Canonical exit: 7 Oct 2015 (T+90)
- 600 shares@ US$1.08Common StockSEC:0001446472-15-000006:0
- 38,985 shares@ US$1.18Common StockSEC:0001446472-15-000006:1Canonical exit: 5 Oct 2015 (T+90)
- 21,015 shares@ US$1.20Common StockSEC:0001446472-15-000006:2Canonical exit: 6 Oct 2015 (T+90)
- 340,000 shares@ US$0.30Common StockSEC:0001181431-14-004744:0Canonical exit: 10 Sept 2013 (T+90)
- 350,000 shares@ US$0.25common stockSEC:0001016193-09-000044:0Canonical exit: 2 Mar 2010 (T+90)
- 400,000 shares@ US$0.25common stockSEC:0001016193-09-000025:0Canonical exit: 11 Jan 2010 (T+90)
11 of 11 declarations
About Bio-Path Holdings Inc
Bio-Path Holdings Inc is a company focused on developing cancer treatments using targeted therapies. It is listed on the NASDAQ under the ticker BPTH.
